1NWS
BMY.RT

1 North Wealth Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

1 North Wealth Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Buy
+33
New +$86 ﹤0.01% 377

Other funds holding BMY.RT

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

1 North Wealth Services's BMY.RT Position: Q4 2019 in Review

1 North Wealth Services opened a new position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2019: 33 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings.

616 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2019.

  • 1 North Wealth Services held 33 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $0 as of Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights was a new 1 North Wealth Services position in Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of 1 North Wealth Services's portfolio in Q4 2019, its #377 holding.
  • 616 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2019.

Based on 1 North Wealth Services's 13F filing for Q4 2019, filed 14 Feb 2020.